The promoter methylation of the TAP1 gene in normal tissue was compared with tissues in patients with different clinical outcomes for breast, liver, lung, and ovarian cancer (Fig. 5 and Supplementary Table 2). The gene discussed is TAP1; the disease is ovarian cancer.